SBRT/LDRT in Combination With Camrelizumab and Apatinib in Metastatic Non-small Cell Lung Cancer Patient Previously Treated With PD-1/L1 Inhibitor and Chemotherapy
Clinical trial NCT04878107 · UNKNOWN
Trial details
- NCT number
- NCT04878107
- Sponsor
- Wuhan University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-03-15
- Primary completion
- 2022-10-01
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.